Retrovirus-mediated IL-4 gene therapy in spontaneous adenocarcinomas from MMTV-neu transgenic mice

M. G. Sacco, S. Benedetti, E. Mira Catò, M. Caniatti, R. Ceruti, E. Scanziani, B. Pirola, A. Villa, G. Finocchiaro, P. Vezzoni

Research output: Contribution to journalArticle

Abstract

Gene therapy approaches to the treatment of experimental cancer are usually based on established neoplastic cell lines which are manipulated in vitro and subsequently transplanted in host animals. However, the relevance of these artificial models to the biology and therapy of human tumors is uncertain. We have previously validated an experimental model based on MMTV-neu transgenic mice in which breast tumors arise spontaneously in 100% of animals and have many features in common with their human counterpart, including the involvement of the neu oncogene and the ability to metastatize. In this article we report the effect of intratumoral, retrovirus-mediated, IL-4 expression on the growth of breast tumors arising in these mice. The size of IL-4 inoculated tumors on the right side was significantly smaller than that of controlateral untreated tumors, suggesting a local effect of IL-4. In addition, the non-injected tumors on the left side of treated animals were significantly smaller than those arising in control transgenic mice, suggesting that IL-4 can also inhibit tumor growth systemically. These findings suggest that IL-4 gene transfer can significantly reduce the growth rate of spontaneously arising breast tumors and that immune-based gene therapy could efficiently complement other approaches based on different mechanisms, such as suicide gene transfer or antisense technology.

Original languageEnglish
Pages (from-to)1893-1897
Number of pages5
JournalGene Therapy
Volume6
Issue number11
DOIs
Publication statusPublished - 1999

    Fingerprint

Keywords

  • Cancer gene therapy
  • IL-4
  • Transgenic

ASJC Scopus subject areas

  • Genetics

Cite this